iDtheinvestordatabase
Home / Directory / Clarevia
Active: new deal May 2026 Verified 5 Nov 2026

Clarevia

Madison healthcare venture investor, now operating as Clarevia, backing pharma, diagnostics, medical device and digital health companies, often from Midwest research universities. Reports $350 million under management.

Type
VC firm
Location
Madison, Wisconsin, United States
Backs
Biotech and pharma, Medtech and digital health
Sectors
Healthtech and life sciences, Biotech
Fund size / AUM
$100M Venture Investors Health Fund 7 Limited Partnership (Form D offering, 2023); $212.4M gross private fund assets (Form ADV; private funds: 8, of which venture capital: 8)
Latest fund or filing
17 Oct 2024
Portfolio mix
Biotech and pharma 48%; Medtech and digital health 45%; B2B software 7% (n=15)

Contacts on file

For Clarevia, the paid file holds: 8 named decision-makers with roles; LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

NeuWave MedicalHistoSonicsViaLaseThird Wave Technologies

Sources

Last checked 5 Nov 2026. Is something wrong? Tell us.

Appears in 9 lists